Impact of Liver Disease on Oral Anticoagulant Prescription and Major Adverse Events in Patients with Atrial Fibrillation: analysis from a population-based cohort study

Marco Proietti, Irene Marzona, Tommaso Vannini, Pierluca Colacioppo, Mauro Tettamanti, Andreana Foresta, Ida Fortino, Luca Merlino, Gregory Y H Lip, Maria Carla Roncaglioni

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)
Original languageEnglish
Article numberpvaa015
JournalEuropean heart journal. Cardiovascular pharmacotherapy
Volume7
Issue numberFI1
Pages (from-to)f84–f92
Number of pages9
ISSN2055-6837
DOIs
Publication statusPublished - Apr 2021

Keywords

  • Atrial fibrillation
  • Liver disease
  • Oral anticoagulant treatment

Fingerprint

Dive into the research topics of 'Impact of Liver Disease on Oral Anticoagulant Prescription and Major Adverse Events in Patients with Atrial Fibrillation: analysis from a population-based cohort study'. Together they form a unique fingerprint.

Cite this